Carles Leal

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas(Current)

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Universidad Autónoma de Madrid

Hospital Universitari Germans Trias i Pujol

Hospital de Sant Pau

Carles Leal is an author at Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas specializing in inflammatory bowel disease care, tumor necrosis factor inhibitor therapy, and inflammatory disease pharmacotherapy.

ORCID

Publications per year

2018–2024

Publications

Adverse Events and Acute Chronic Liver Failure in Patients With Cirrhosis Undergoing Endoscopic Retrograde Cholangiopancreatography: A Multicenter Matched-Cohort Study

Carles Leal, Verónica Prado, Juan Colán‐Hernández et al. · The American Journal of Gastroenterology · 2018 · 31 citations

Medicine, Internal Medicine, Clinical Epidemiology +16

Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn’s Disease (Versus-CD): Data from the ENEIDA Registry

María José García, Montserrat Rivero, A Fernández-Clotet et al. · Journal of Crohn s and Colitis · 2023 · 19 citations

Pharmacy, Immunology, Pharmacotherapy +15

Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

Carla J. Gargallo-Puyuelo, Elena Ricart, Eva Iglesias et al. · Clinical Gastroenterology and Hepatology · 2024 · 14 citations

Medicine, Immunology, Pathobiology +16

Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the <scp>PROCU</scp> study of the <scp>ENEIDA</scp> registry

Rocío Ferreiro‐Iglesias, Sol Porto Silva, Sandra Soro Marín et al. · Alimentary Pharmacology & Therapeutics · 2024 · 10 citations

Medicine, Immunology, Internal Medicine +17

1–4 of 4